Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 2;12(15):5076.
doi: 10.3390/jcm12155076.

Advanced Localization Technique for Non-Palpable Breast Cancer: Radiofrequency alone VS Combined Technique with Ultrasound

Simona Parisi  1   2 , Claudio Gambardella  1   2 , Giovanni Conzo  3 , Roberto Ruggiero  1 , Salvatore Tolone  1 , Francesco Saverio Lucido  1 , Francesco Iovino  3 , Francesca Fisone  1 , Luigi Brusciano  1 , Domenico Parmeggiani  1 , Ludovico Docimo  2
Affiliations

Advanced Localization Technique for Non-Palpable Breast Cancer: Radiofrequency alone VS Combined Technique with Ultrasound

Simona Parisi et al. J Clin Med. .

Abstract

Breast conservative surgery is the primary therapeutic choice for non-aggressive early breast cancers, and a minimally-invasive approach is strongly recommended. The breast localization represents a modern challenge for surgery. Wire-guided localization is still the gold standard technique, but new wireless systems have been proposed, such as radiofrequency identification with LOCalizerTM (Hologic, Santa Carla, CA, USA), which reports encouraging results. The current study aimed to evaluate the accuracy and efficacy of the combined use of LOCalizerTM and ultrasound compared with the results obtained using LOCalizerTM alone for the detection of non-palpable breast cancer. Ninety-six patients who were candidates for breast localization were enrolled. Group A received a combined localization with LOCalizerTM and US, while group B underwent only LOCalizerTM identification. Oncological radicality was reached in 100% of the patients in Group A and in 89.2% of the patients in Group B, with p = 0.006. The mean specimens' volume was 13.2 ± 0.6 cm3 for Group A and 16.1 ± 1.4 cm3 for Group B, while mean specimen weights were 21.8 ± 2.2 and 24.4 ± 1.8 g, respectively (p = 0.003 and p = 0.004, respectively). LOCalizerTM with ultrasound, in the current series, has resulted in the preferred option for the localization of non-palpable breast cancer, allowing limited resection (in weight and volume), guaranteeing excellent oncological outcomes, and great satisfaction for patients and physicians.

Keywords: LOCalizer; breast localization; early breast cancer; radiofrequency localization; ultrasound breast localization.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Breast localization withLOCalizerTM.
See this image and copyright information in PMC

References

    1. Katsura C., Ogunmwonyi I., Kankam H.K., Saha S. Breast cancer: Presentation, investigation and management. Br. J. Hosp. Med. 2022;83:1–7. doi: 10.12968/hmed.2021.0459. - DOI - PubMed
    1. Philips N., Coldman A. Comparison of nonbreast cancer incidence, survival and mortality between breast screening program participants and nonparticipants. Int. J. Cancer. 2008;122:197–201. doi: 10.1002/ijc.23024. - DOI - PubMed
    1. Cardoso F., Kyriakides S., Ohno S., Penault-Llorca F., Poortmans P., Rubio I.T., Zackrisson S., Senkus E. ESMO Guidelines Committee. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2019;30:1194–1220. doi: 10.1093/annonc/mdz173. - DOI - PubMed
    1. Coates A.S., Winer E.P., Goldhirsch A., Gelber R.D., Gnant M., Piccart-Gebhart M., Thürlimann B., Senn H.J. Panel Members. Tailoring therapies—Improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann. Oncol. 2015;26:1533–1546. doi: 10.1093/annonc/mdv221. - DOI - PMC - PubMed
    1. Tardioli S., Ballesio L., Gigli S., Di Pastena F., D’Orazi V., Giraldi G., Monti M., Amabile M.I., Pasta V. Wire-guided Localization in Non-palpable Breast Cancer: Results from Monocentric Experience. Anticancer Res. 2016;36:2423–2427. - PubMed

LinkOut - more resources